Health News Releases

  • Today February 18
September 08, 2016 10:25
Takeda Initiates Global Phase 3 Clinical Trial (TIDES) of Dengue Vaccine Candidate (TAK-003)
Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that it has vaccinated the first subject in the Tetravalent Immunization against Dengue Efficacy Study (TIDES), a Phase 3
September 07, 2016 11:30
Tiotropium Respimat® improved lung function in children with asthma aged 6-17 and is well-tolerated compared to placebo in children aged 1-17[1-5]
Boehringer Ingelheim announced today new study results from the Phase III CanoTinA-asthma® trial that showed adding tiotropium Respimat® to maintenance asthma therapy significantly improved lung funct
September 06, 2016 10:15
New Data: Spiolto® Respimat® significantly improves exercise capacity in people with COPD
Boehringer Ingelheim today announced the first results from the Phase III PHYSACTO® trial that shows Spiolto® (tiotropium+olodaterol) Respimat®, combined with exercise training, helps people with COPD
September 06, 2016 09:55
Simple blood test combined with exacerbation history may help to identify when to add ICS to COPD treatment
Boehringer Ingelheim today announced a new post-hoc subanalysis of the WISDOM study that suggests only 4 out of 100 people with chronic obstructive pulmonary disease (COPD), who have a history of freq
September 02, 2016 13:55
ReSound® Returns to the World’s Largest Consumer Electronics Show in Berlin to Showcase the Most Advanced Hearing Solutions
ReSound returns this week to IFA, the world’s largest international consumer electronics show, to feature its award winning Smart Hearing aids and to help lead the current discussion on how to support
September 02, 2016 10:10
Takeda to develop Zika Vaccine with up to $312 million in funding from US Government
Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that BARDA, the Biomedical Advanced Research and Development Authority, has selected Takeda’s Vaccine Business Unit to dev
September 01, 2016 14:05
Takeda Launches Largest Pharmaceutical Company-Sponsored Global Observational Study of Its Kind in Multiple Myeloma
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that its global non-interventional, observational multiple myeloma study is now enrolling patients. Titled INSIGHT-MM, the study aims
August 31, 2016 13:35
GORE® DrySeal Flex Introducer Sheath Advances Care through Access
W. L. Gore & Associates, Inc. (Gore) today announced the commercial availability of the GORE® DrySeal Flex Introducer Sheath, after recently gaining clearance for use by regulatory bodies in the U.S.,
August 30, 2016 19:15
ESC Congress 2016 Late Breaking Science Registry
First outcome results from the GLORIA™-AF Registry show that treatment with dabigatran etexilate was associated with low incidences of stroke, major bleeding and life-threatening bleeding. The results
August 30, 2016 19:10
Masimo Announces Four-Year Partnership with World Federation of Societies of Anaesthesiologists (WFSA)
Masimo (NASDAQ: MASI) announced Sunday at the World Congress of Anaesthesiologists (WCA) in Hong Kong that it has become the first Global Impact Partner of the World Federation of Societies of Anaesth
August 30, 2016 14:00
Masimo Announces a Special Worldwide Program for Total Hemoglobin (SpHb®) Monitoring for Areas Affected by the Zika Virus
Masimo (NASDAQ: MASI) announced today that in response to the Zika virus and its potential impact on the availability of blood products, Masimo is creating a special program to dramatically reduce the
August 30, 2016 13:40
IMS Health and Quintiles Announce Key Officers for Merged Company
IMS Health Holdings, Inc. (NYSE:IMS) and Quintiles Transnational Holdings Inc. (NYSE:Q) today announced key senior management roles in the future Quintiles IMS corporate leadership team, subject to th
August 29, 2016 17:45
Ferring Pharmaceuticals Acquires Exclusive Licensing Rights to Condoliase from Seikagaku Corporation
Ferring Pharmaceuticals announced today that it has signed an agreement with Seikagaku Corporation granting Ferring the exclusive worldwide rights (excluding Japan) to SI-6603 (condoliase), a chemonuc
August 29, 2016 11:20
Takeda Announces Bold, New Access to Medicines Strategy
Takeda Pharmaceutical Company Limited (TOKYO:4502) today announced the launch of a bold, new Access to Medicines (AtM) strategy, aimed at increasing access to its innovative and potentially life-savin
August 19, 2016 14:00
Masimo Announces CE Marking for RAS-45 Sensor for rainbow Acoustic Monitoring® of Respiration Rate
Masimo (NASDAQ: MASI) announced today the CE Marking of RAS-45, a single-use adult and pediatric acoustic respiration sensor for rainbow Acoustic Monitoring® (RAM™) of respiration rate (RRa®). Cont
August 17, 2016 16:00
Piramal Enterprises Enters into an Agreement to Acquire Ash Stevens Inc., a US based CDMO for High Potency APIs (HPAPIs)
Piramal Enterprises Limited (PEL, NSE: PEL, BSE: 500302) announced today that its wholly owned subsidiary in the US has entered into an agreement to acquire 100% stake in Ash Stevens Inc., a US based
August 17, 2016 14:10
Outcomes of Presbia Microlens Surgeries in Korean Study Demonstrate Excellent Results
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced the 12-month results of the 14 Presbia Flexivue Microlens™ surgeries performed on South Korean
August 16, 2016 13:35
Boehringer Ingelheim launches RE-VECTO global program to capture data on Praxbind® usage in clinical practice
Boehringer Ingelheim today announces its global RE-VECTO program for Praxbind® (idarucizumab), the specific reversal agent for Pradaxa® (dabigatran etexilate).[1,2] Praxbind® is approved to reverse th
August 09, 2016 22:30
With Sleep Medicine Launch, Wolters Kluwer Expands UpToDate Coverage to 24 Specialties
The Health division of Wolters Kluwer, a leading global provider of information and point-of-care solutions for the healthcare industry, announced today that it has added sleep medicine to UpToDate®,
August 09, 2016 09:41
Takeda Receives Marketing Authorization in Canada for NINLARO™(ixazomib) in Relapsed/Refractory Multiple Myeloma
Takeda Pharmaceutical Company Limited (TSE:4502) today announced Takeda Canada has received approval from Health Canada for NINLARO™ (ixazomib) capsules in combination with lenalidomide and dexamethas
August 05, 2016 10:50
Masimo Announces CE Marking for Pediatric O3™ Regional Oximetry
Masimo (NASDAQ: MASI) announced today the CE marking for the pediatric indication for O3™ regional oximetry with the O3 pediatric sensor. Regional oximetry, also referred to as tissue or cerebral oxim
August 03, 2016 11:55
Quintiles and DaVita Clinical Research Announce Strategic Alliance
Quintiles, the world’s largest provider of product development and integrated healthcare services, and DaVita Clinical Research, a wholly-owned subsidiary of DaVita HealthCare Partners Inc., a leader
August 01, 2016 19:55
Takeda and Seattle Genetics Announce Positive Data from Phase 3 ALCANZA Clinical Trial of ADCETRIS® (Brentuximab Vedotin) for CD30-Expressing Cutaneous T-Cell Lymphoma
Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ:SGEN) today announced that the Phase 3 ALCANZA clinical trial evaluating ADCETRIS (brentuximab vedotin) in patients
August 01, 2016 10:40
Takeda Reports 1st Quarter 2016 Results with a Strong Start to the Year and Confidence in Management Guidance
Takeda Pharmaceutical Company Limited (TOKYO:4502): Strong first quarter results and confidence in Management Guidance · Underlying revenue grew +9.1%, driven by a +15.3% increase of Takeda's Grow
July 28, 2016 15:30
Mannatech Launches Proprietary Essential Oils Line in Korea
Mannatech®, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, has recently expanded its line of proprietary essential oils and G
25 per page50 per page75 per page100 per page